Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $4.66 billion. The enterprise value is $4.37 billion.
| Market Cap | 4.66B |
| Enterprise Value | 4.37B |
Important Dates
The next confirmed earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 20.04 million shares outstanding. The number of shares has increased by 10.96% in one year.
| Current Share Class | 20.04M |
| Shares Outstanding | 20.04M |
| Shares Change (YoY) | +10.96% |
| Shares Change (QoQ) | +2.47% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 105.35% |
| Float | 19.47M |
Valuation Ratios
The trailing PE ratio is 37.90 and the forward PE ratio is 40.83. LGND's PEG ratio is 2.17.
| PE Ratio | 37.90 |
| Forward PE | 40.83 |
| PS Ratio | 17.34 |
| Forward PS | 17.11 |
| PB Ratio | 4.51 |
| P/TBV Ratio | 6.73 |
| P/FCF Ratio | 95.05 |
| P/OCF Ratio | 94.18 |
| PEG Ratio | 2.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 53.93, with an EV/FCF ratio of 89.29.
| EV / Earnings | 35.09 |
| EV / Sales | 16.29 |
| EV / EBITDA | 53.93 |
| EV / EBIT | 92.52 |
| EV / FCF | 89.29 |
Financial Position
The company has a current ratio of 22.23, with a Debt / Equity ratio of 0.44.
| Current Ratio | 22.23 |
| Quick Ratio | 21.83 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 5.52 |
| Debt / FCF | 9.23 |
| Interest Coverage | 10.01 |
Financial Efficiency
Return on equity (ROE) is 13.47% and return on invested capital (ROIC) is 5.02%.
| Return on Equity (ROE) | 13.47% |
| Return on Assets (ROA) | 2.36% |
| Return on Invested Capital (ROIC) | 5.02% |
| Return on Capital Employed (ROCE) | 3.10% |
| Weighted Average Cost of Capital (WACC) | 8.98% |
| Revenue Per Employee | $5.70M |
| Profits Per Employee | $2.65M |
| Employee Count | 47 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 8.24 |
Taxes
In the past 12 months, LGND has paid $34.51 million in taxes.
| Income Tax | 34.51M |
| Effective Tax Rate | 21.71% |
Stock Price Statistics
The stock price has increased by +115.43% in the last 52 weeks. The beta is 1.00, so LGND's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +115.43% |
| 50-Day Moving Average | 207.99 |
| 200-Day Moving Average | 185.57 |
| Relative Strength Index (RSI) | 60.65 |
| Average Volume (20 Days) | 219,559 |
Short Selling Information
The latest short interest is 1.41 million, so 7.02% of the outstanding shares have been sold short.
| Short Interest | 1.41M |
| Short Previous Month | 1.50M |
| Short % of Shares Out | 7.02% |
| Short % of Float | 7.23% |
| Short Ratio (days to cover) | 5.62 |
Income Statement
In the last 12 months, LGND had revenue of $268.09 million and earned $124.45 million in profits. Earnings per share was $6.13.
| Revenue | 268.09M |
| Gross Profit | 172.36M |
| Operating Income | 47.20M |
| Pretax Income | 158.96M |
| Net Income | 124.45M |
| EBITDA | 80.97M |
| EBIT | 47.20M |
| Earnings Per Share (EPS) | $6.13 |
Balance Sheet
The company has $733.52 million in cash and $451.54 million in debt, with a net cash position of $281.98 million or $14.07 per share.
| Cash & Cash Equivalents | 733.52M |
| Total Debt | 451.54M |
| Net Cash | 281.98M |
| Net Cash Per Share | $14.07 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 51.44 |
| Working Capital | 794.82M |
Cash Flow
In the last 12 months, operating cash flow was $49.36 million and capital expenditures -$452,000, giving a free cash flow of $48.91 million.
| Operating Cash Flow | 49.36M |
| Capital Expenditures | -452,000 |
| Depreciation & Amortization | 33.78M |
| Net Borrowing | 346.72M |
| Free Cash Flow | 48.91M |
| FCF Per Share | $2.44 |
Margins
Gross margin is 64.29%, with operating and profit margins of 17.61% and 46.42%.
| Gross Margin | 64.29% |
| Operating Margin | 17.61% |
| Pretax Margin | 59.29% |
| Profit Margin | 46.42% |
| EBITDA Margin | 30.20% |
| EBIT Margin | 17.61% |
| FCF Margin | 18.24% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.96% |
| Shareholder Yield | -10.96% |
| Earnings Yield | 2.68% |
| FCF Yield | 1.05% |
Analyst Forecast
The average price target for LGND is $249.71, which is 7.49% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $249.71 |
| Price Target Difference | 7.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 12.79% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 1:6.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
LGND has an Altman Z-Score of 4.44 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.44 |
| Piotroski F-Score | 5 |